Frontiers in neuroscience
The most recent articles from:
Front Neurosci
-
Frontiers in neuroscience · Jan 2016
Retracted PublicationAtorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma.
Chronic subdural hematoma (CSDH) is a common form of intracranial hemorrhage with a substantial recurrence rate. Atorvastatin may reduce CSDH via its anti-inflammatory and pro-angiogenesis effects, but its effectiveness for preventing recurrent CSDH has never been explored. We hypothesized that atorvastatin is effective in reducing recurrence of CSDH after surgery and identified determining factors predictive of hematoma recurrence. ⋯ Atorvastatin administration may decrease the risks of recurrence.Patients with severe brain atrophy and bilateral CSDH are prone to the recurrence.